Bicycle Therapeutics Ltd (BCYC) Insider Trading
- $10,800,006.00
- $14,858,579.44
- April 11, 2024
- Kevin Lee
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 12, 2021 | Insider | 9,783 | $28.50 | Sell | $278,815.50 | |
| March 12, 2021 | Director | 2,216 | $29.00 | Sell | $64,264.00 | |
| Jan. 19, 2021 | CFO | 15,000 | $30.00 | Sell | $450,000.00 | |
| Jan. 19, 2021 | CEO | 5,000 | $29.26 | Sell | $146,300.00 | |
| Jan. 15, 2021 | CEO | 10,000 | $26.01 | Sell | $260,100.00 | |
| Dec. 1, 2020 | CFO | 7,500 | $22.50 | Sell | $168,750.00 | |
| Nov. 27, 2020 | CFO | 530 | $20.00 | Sell | $10,600.00 | |
| Nov. 25, 2020 | CFO | 9,781 | $20.07 | Sell | $196,304.67 | |
| Nov. 23, 2020 | CFO | 17,189 | $19.83 | Sell | $340,857.87 | |
| July 14, 2020 | Major Shareholder | 1,597 | $19.27 | Sell | $30,774.19 | |
| May 28, 2019 | Major Shareholder | 385,715 | $14.00 | Buy | $5,400,010.00 | |
| May 28, 2019 | Director | 385,714 | $14.00 | Buy | $5,399,996.00 |
Insiders are both buying and selling Bicycle Therapeutics Ltd stock.
The insider traders at Bicycle Therapeutics Ltd are: Kevin Lee, Lee Kalowski, Nicholas Keen, Pierre Legault, Travis Alvin Thompson, Nigel Crockett, Michael Skynner, Michael Charles Ferguso Hannay, Deborah Harland, Kate Bingham, Life Sciences Fund V Lp Sv, Alistair Milnes, and Plc Glaxosmithkline
The most active insider trader at Bicycle Therapeutics Ltd is Kevin Lee with 23 trades.
Pierre Legault has sold the most Bicycle Therapeutics Ltd stock with a total value of $6,169,662.46.
Life Sciences Fund V Lp Sv has bought the most Bicycle Therapeutics Ltd stock with a total value of $10,800,020.00.
The most recent insider trade for Bicycle Therapeutics Ltd was on April 11, 2024.
The single biggest insider buy for Bicycle Therapeutics Ltd was from Life Sciences Fund V Lp Sv with a total value of $5,400,010.00 on May 28, 2019.
The single biggest insider sell for Bicycle Therapeutics Ltd was from Pierre Legault with a total value of $2,543,508.07 on Dec. 21, 2021.